Table 2 Factors associated with myosteatosis according to univariate and multivariate logistic analysis in patients with ACLF.
From: Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age | 1.084 (1.059–1.108) | < 0.001 | 1.074 (1.046–1.102) | < 0.001 |
Sex | ||||
Males | Ref | Ref | ||
Females | 8.697 (3.671–20.605) | < 0.001 | 12.648 (4.242–37.712) | < 0.001 |
Aetiology | ||||
HBV | Ref | Ref | ||
Alcohol | 3.308 (1.965–5.567) | < 0.001 | 3.098 (1.676–5.725) | < 0.001 |
HBV + Alcohol | 0.764 (0.390–1.499) | 0.434 | 0.951 (0.453–1.997) | 0.894 |
Other | 3.141 (1.529–6.455) | 0.002 | 0.422 (0.150–1.185) | 0.101 |
Liver cirrhosis | 1.844 (1.166–2.915) | 0.009 | 1.541 (0.899–2.643) | 0.116 |
Diabetes | 0.932 (0.555–1.566) | 0.791 | ||
Sarcopenia | 4.327 (2.351–7.963) | < 0.001 | 4.002 (1.595–10.046) | 0.003 |
VSR | 1.440 (1.009–2.056) | 0.045 | 0.987 (0.602–1.619) | 0.959 |
VATI | 1.003 (0.995–1.011) | 0.456 | ||
SATI | 1.000 (0.993–1.007) | 0.957 | ||
Visceral obesity | 0.792 (0.537–1.170) | 0.242 | ||
Sarcopenic obesity | 4.094 (1.680–9.978) | 0.002 | 1.041 (0.284–3.810) | 0.952 |
